Riva, CamilloJacobs, Victor Jasper Jean2024-11-122024-11-122024-01-232023-12-20http://hdl.handle.net/10362/175025This report is an equity valuation of Koninklijke Philips N.V., a global leader in healthcare technology and based in the Netherlands. The company has over a century of experience and operates in 3 business units: Diagnostic and Imaging, Connected Care and Personal Health. In august 2023, Exor N.V bought a 15% shareholding in Philips. Therefore, fully supporting Philips’ leadership, strategy, and value creation potential. Philips has to a two-tier board structure consisting of a Board of Management and a Supervisory Board. Over the past decade, Philips has transformed into a high-tech health technology company, focusing on high-growth healthcare sectors. Their strategic direction addresses challenges such as an aging population and healthcare costs, aiming to deliver efficient, data-driven solutions. This equity report employs a bottom-up approach to estimate market sizes for Philips. Using product-level sales data, ratios, and national statistics, the report projects market sizes based on factors like population, ICU units per inhabitant, and price per ICU unit. The approach is transparent but relies on simplifying assumptions detailed in the accompanying Excel file. Market sizes were crosschecked with analyst consensus, and growth geographies were analyzed using region-wide GDP growth as a proxy for healthcare spending. Assumptions and methodologies aim to balance accuracy with practicality.engPhilipsKoninklijke philips n.v.HealthcareHealthcare technologymaster thesis203603362